[1]
S. Erba, A. Scialdone, and G. Casalino, “Intravitreal Bevacizumab in Neovascular Age-Related Macular Degeneration as First Choice: a New Italian Ruling”, Med Hypothesis Discov Innov Ophthalmol, vol. 9, no. 3, pp. 179-184, Jun. 2020.